260 results
DEFA14A
BDTX
Black Diamond Therapeutics Inc
24 Apr 24
Additional proxy soliciting materials
4:02pm
Materials
Soliciting Material under §240.14a-12
BLACK DIAMOND THERAPEUTICS, INC.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s … a control number For complete information and to vote, visit www.ProxyVote.com Control # V40401-P07941 BLACK DIAMOND THERAPEUTICS, INC. Virtually
PRE 14A
BDTX
Black Diamond Therapeutics Inc
12 Apr 24
Preliminary proxy
4:48pm
Materials
Soliciting Material under §240.14a-12
BLACK DIAMOND THERAPEUTICS, INC.
(Name of registrant as specified in its charter)
(Name of Person(s … STATEMENT — SUBJECT TO COMPLETION, DATED APRIL 12, 2024
BLACK DIAMOND THERAPEUTICS, INC.
One Main Street, 14th Floor
Cambridge, MA 02142
NOTICE OF 2024
8-K
EX-99.1
BDTX
Black Diamond Therapeutics Inc
11 Apr 24
Black Diamond Therapeutics Announces Changes to Board of Directors
8:03am
Exhibit 99.1
Black Diamond Therapeutics Announces Changes to Board of Directors
CAMBRIDGE, Mass., April 11, 2024 (GLOBE NEWSWIRE) – Black Diamond … ,” said Mark Velleca, M.D., Ph.D., Chief Executive Officer of Black Diamond Therapeutics. “I would also like to thank Alex for his many years
8-K
BDTX
Black Diamond Therapeutics Inc
11 Apr 24
Black Diamond Therapeutics Announces Changes to Board of Directors
8:03am
Exchange Act of 1934
Date of Report (Date of earliest event reported): April 10, 2024
BLACK DIAMOND THERAPEUTICS, INC.
(Exact name of registrant … , Ph.D. resigned from the Board of Directors (the “Board”) of Black Diamond Therapeutics, Inc. (the “Company”). Dr. Mayweg’s decision to resign from
S-8
hbw4to
12 Mar 24
Registration of securities for employees
8:01am
S-8
EX-5.1
8cmatmwfs0s5diz1 jx
12 Mar 24
Registration of securities for employees
8:01am
S-8
r96cdzon pvdn
12 Mar 24
Registration of securities for employees
8:01am
S-8
EX-23.1
s4z1lvmv czih02t8y4
12 Mar 24
Registration of securities for employees
8:01am